Cargando…
Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%
PURPOSE: To examine the pooled per-protocol ocular end points from two conjunctival allergen challenge (CAC) clinical trials of the dual-action antihistamine bepotastine besilate ophthalmic solution (BBOS) 1.5%. METHODS: Two Phase III, placebo-controlled, double-masked, randomized clinical trials we...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140238/ https://www.ncbi.nlm.nih.gov/pubmed/25152611 http://dx.doi.org/10.2147/OPTH.S66637 |